Reproducible image-based profiling with Pycytominer

E Serrano, SN Chandrasekaran, D Bunten, KI Brewer… - Ar**v, 2024 - pmc.ncbi.nlm.nih.gov
Advances in high-throughput microscopy have enabled the rapid acquisition of large
numbers of high-content microscopy images. Whether by deep learning or classical …

In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer's disease

LM Sanchez-Rodriguez, AF Khan… - Frontiers in aging …, 2024 - frontiersin.org
The molecular mechanisms underlying neuronal dysfunction in Alzheimer's disease (AD)
remain uncharacterized. Here, we identify genes, molecular pathways and cellular …

Transcriptionally Conditional Recurrent Neural Network for De Novo Drug Design

Y Matsukiyo, A Tengeiji, C Li… - Journal of Chemical …, 2024 - ACS Publications
Computational molecular generation methods that generate chemical structures from gene
expression profiles have been actively developed for de novo drug design. However, most …

Transcriptomic signatures of Aβ-and tau-induced neuronal dysfunction reveal inflammatory processes at the core of Alzheimer's disease pathophysiology

LM Sanchez-Rodriguez, AF Khan, Q Adewale… - bioRxiv, 2023 - biorxiv.org
Molecular mechanisms enabling pathology-induced neuronal dysfunction in Alzheimer's
disease (AD) remain elusive. Here, we use mechanistic computational models to infer the …

[PDF][PDF] Dex-Benchmark: datasets and code to evaluate algorithms for transcriptomics data analysis

Z **e, C Chen, A Ma'ayan - PeerJ, 2023 - peerj.com
Many tools and algorithms are available for analyzing transcriptomics data. These include
algorithms for performing sequence alignment, data normalization and imputation …

Using Phenotypic Screening to Uncover the Full Potential of Polypharmacology

A Nueda - Polypharmacology: Strategies for Multi‐Target Drug …, 2025 - Wiley Online Library
Phenotypic screening and, more generally, phenotypic drug discovery (PDD) have proven
their potential to capture novel polypharmacology‐based mechanisms of action (MoA) that …

Cross-disease modeling of peripheral blood identifies biomarkers of type 2 diabetes predictive of Alzheimer's disease

BK Ball, JH Park, EA Proctor, DK Brubaker - bioRxiv, 2024 - biorxiv.org
Type 2 diabetes (T2D) is a significant risk factor for Alzheimer's disease (AD). Despite
multiple studies reporting this connection, the mechanism by which T2D exacerbates AD is …

Exploring cutting-edge strategies for drug repurposing in female cancers-An insight into the tools of the trade.

KS Satish, GR Saraswathy, G Ritesh… - Progress in Molecular …, 2024 - europepmc.org
Female cancers, which include breast and gynaecological cancers, represent a significant
global health burden for women. Despite advancements in research pertinent to unearthing …

A Deep Learning Approach for Single-Cell Perturbation Prediction Using Small Molecule Chemical Structures

C Zhang, F Bi, J Zhang, G Chen - International Symposium on Neural …, 2024 - Springer
In this study, we develop a deep learning framework aimed at predicting the impacts of
chemical perturbations on individual cells, emphasizing the encoding of small molecular …

[PDF][PDF] In-vivo neuronal dysfunction by

LM Sanchez-Rodriguez, AF Khan, H Jiang, X Chai… - 2024 - scienceopen.com
Neuronal dysfunction in Alzheimer's disease (AD) is associated with toxic protein
accumulation, including amyloid beta (Aβ) plaques and tau neurofibrillary tangles …